CA2222429A1 - Milieu de contraste et son utilisation - Google Patents

Milieu de contraste et son utilisation Download PDF

Info

Publication number
CA2222429A1
CA2222429A1 CA002222429A CA2222429A CA2222429A1 CA 2222429 A1 CA2222429 A1 CA 2222429A1 CA 002222429 A CA002222429 A CA 002222429A CA 2222429 A CA2222429 A CA 2222429A CA 2222429 A1 CA2222429 A1 CA 2222429A1
Authority
CA
Canada
Prior art keywords
cells
contrast medium
protecting
agent
contrast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002222429A
Other languages
English (en)
Inventor
Avi Dascalu
Rafi Korenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARELL AVIKAM
Israel Humanitarian Foundation Ltd
Jade Holding Inc Bvi
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2222429A1 publication Critical patent/CA2222429A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0452—Solutions, e.g. for injection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention se rapporte à un milieu de contraste qui renferme une quantité efficace d'agents de contraste et d'un agent de protection, lequel protège activement l'usager contre d'éventuels effets néfastes induits par le milieu en question.
CA002222429A 1995-05-31 1996-05-24 Milieu de contraste et son utilisation Abandoned CA2222429A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL113926 1995-05-31
IL11392695A IL113926A (en) 1995-05-31 1995-05-31 Contrast medium with improved patient's tolerance thereto and its use

Publications (1)

Publication Number Publication Date
CA2222429A1 true CA2222429A1 (fr) 1996-12-05

Family

ID=11067540

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002222429A Abandoned CA2222429A1 (fr) 1995-05-31 1996-05-24 Milieu de contraste et son utilisation

Country Status (5)

Country Link
EP (1) EP0863770A4 (fr)
AU (1) AU707118B2 (fr)
CA (1) CA2222429A1 (fr)
IL (1) IL113926A (fr)
WO (1) WO1996038183A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2191118A (en) * 1937-06-03 1940-02-20 Firm Of N V Orgachemia Pyelographic preparation
US2870063A (en) * 1955-07-05 1959-01-20 Mallinckrodt Chemical Works X-ray contrast composition comprising substantially amylose-free amylopectin in aqueous solution of contrast agent
US3984571A (en) * 1970-03-10 1976-10-05 E. R. Squibb & Sons, Inc. Hydrocolloid containing liquid carrier for a diagnostic or therapeutic agent
US5847009A (en) * 1986-01-14 1998-12-08 Alliance Pharmaceutical Corp. Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
USRE34077E (en) * 1988-05-02 1992-09-22 Cryomedical Sciences, Inc. Blood substitute
FR2635327B1 (fr) * 1988-08-10 1990-11-16 Guerbet Sa Polymeres iodes, a squelette dextrane, leurs procedes de preparation et leurs applications comme produits de contraste
US5019370A (en) * 1989-07-10 1991-05-28 University Of Kentucky Research Foundation Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging
US5199951A (en) * 1990-05-17 1993-04-06 Wayne State University Method of drug application in a transporting medium to an arterial wall injured during angioplasty
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
DE19518221A1 (de) * 1995-05-10 1996-11-14 Schering Ag Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen

Also Published As

Publication number Publication date
WO1996038183A1 (fr) 1996-12-05
IL113926A (en) 2000-06-01
IL113926A0 (en) 1995-08-31
EP0863770A1 (fr) 1998-09-16
AU5930996A (en) 1996-12-18
AU707118B2 (en) 1999-07-01
EP0863770A4 (fr) 2001-01-10

Similar Documents

Publication Publication Date Title
Seltzer et al. Instant nutritional assessment
CN1899614B (zh) 预防再狭窄的制剂
Scheffel et al. Glenohumeral chondrolysis: a systematic review of 100 cases from the English language literature
Strömqvist Femoral Head Vitality After Intracapsular Hip Fracture: 490 Cases Studied by Intravital Tetracyche Labeling and Tc-MDP Radionuclide Imaging.
ES2593127T3 (es) Proceso para preparar una formulación farmacéutica de agentes de contraste
Binning et al. Rathke cleft cyst intracystic nodule: a characteristic magnetic resonance imaging finding
Kusuzaki et al. Acridine orange could be an innovative anticancer agent under photon energy
Yildirgan et al. Intrabiliary rupture in liver hydatid cysts: results of 20 years’ experience
IE66694B1 (en) Chelate compositions
US6149891A (en) X-ray contrast medium and method for protecting against harmful effects thereof
Ismaeel et al. Role of high resolution contrast-enhanced magnetic resonance angiography (HR CeMRA) in management of arterial complications of the renal transplant
Böckler et al. Endoluminal stent-graft repair of aortobronchial fistulas: bridging or definitive long-term solution?
AU707118B2 (en) Contrast medium and its use
Higashi et al. Pineal apoplexy.
Sueyoshi et al. Infected abdominal aortic aneurysm: early CT findings
EA023535B1 (ru) Композиция водного радиопротекторного фармацевтического раствора и способ предотвращения, снижения или исключения эффектов ионизирующей радиации
Purcell et al. A unique case of extra-articular extravasation of metal into the lower leg resulting from oxidized zirconium wear particles from total knee arthroplasty
Cornelissen et al. Visualizing type IV endoleak using magnetic resonance imaging with a blood pool contrast agent
YANAKA et al. Combined carotid endarterectomy and coronary artery bypass graft
Proust et al. Tentorial edge traumatic aneurysm of the superior cerebellar artery: case report
Matsuura et al. A case report of venous aneurysm of the neck vein
Giannoni et al. Role of contrast-enhanced ultrasound in the follow-up of endo-vascular aortic aneurysm repair: an effective and safe surveillance method
BJÖRK et al. A new type of contrast medium in arthrography
Biyase Contrast and dyes
Khazindar A case of stump appendicitis secondary to appendicular fecolith

Legal Events

Date Code Title Description
FZDE Discontinued